Bexxar tositumomab regulatory update

CLTR will meet with the FDA this month to discuss the resubmission of its BLA for its Bexxar radiolabeled anti- CD20 monoclonal antibody to treat non-Hodgkin's lymphoma following the FDA's decision th...